跳至主要内容
临床试验/NCT04359836
NCT04359836招募中不适用

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection

ProgenaBiome1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2020年4月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250
试验地点
1
主要终点
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing

研究概览

简要总结

This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.

详细描述

In this study the stool of patients who are being treated for COVID-19 will be tested during treatment and then again following treatment to determine if the virus is shed in the stool during infection, afterwards, or both.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  • Male or female of 18 years of age or older
  • Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening

排除标准

  • Refusal to sign informed consent form
  • History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
  • Postoperative stoma, ostomy, or ileoanal pouch
  • Treatment with total parenteral nutrition

结局指标

主要结局

Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing

时间窗: One year

Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific gastrointestinal disease types.

次要结局

  • Validation of Sequencing Methods(One year)

研究者

发起方
ProgenaBiome
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study to Explore the Role of Gut Flora in COVID-19... | 临床试验